{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:15:22Z","timestamp":1780409722793,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jneuroim.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T06:44:17Z","timestamp":1518158657000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The clinical features of combined central and peripheral demyelination in Chinese patients"],"prefix":"10.1016","volume":"317","author":[{"given":"Yan-Qin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Ping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3018-7297","authenticated-orcid":false,"given":"Hong-Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.02.006_bb0005","first-page":"32","article-title":"Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis","volume":"20","author":"Ayromlou","year":"2013","journal-title":"Malays. J. Med. Sci."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1468-1331.2011.03495.x","article-title":"Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis","volume":"18","author":"Cocito","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jns.2016.02.022","article-title":"Combined central and peripheral demyelination: clinical features, diagnostic findings, and treatment","volume":"363","author":"Cortese","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10072-006-0565-3","article-title":"Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy","volume":"27","author":"Falcone","year":"2006","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb3330","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/jnnp.42.9.864","article-title":"Association between polyneuritis and multiple sclerosis","volume":"42","author":"Forrester","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0035","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/135245850100700309","article-title":"Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy","volume":"7","author":"Khan","year":"2001","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.20412","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy with tumefactive central demyelination","volume":"33","author":"Krivickas","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0050","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1179\/1743132814Y.0000000400","article-title":"Clinical characteristics and outcomes of patients with Guillain-Barre and acquired CNS demyelinating overlap syndrome: a cohort study based on a literature review","volume":"36","author":"Mao","year":"2014","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0976-3147.127887","article-title":"Central and peripheral demyelination","volume":"5","author":"Mehndiratta","year":"2014","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0060","first-page":"29","article-title":"A nationwide survey of combined central and peripheral demyelination in Japan","volume":"87","author":"Ogata","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0075","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/S1388-2457(00)00478-8","article-title":"Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy","volume":"111","author":"Stojkovic","year":"2000","journal-title":"Clin. Neurophysiol."},{"issue":"Pt 1","key":"10.1016\/j.jneuroim.2018.02.006_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/brain\/110.1.53","article-title":"Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination","volume":"110","author":"Thomas","year":"1987","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/cjn.2015.238","article-title":"Fulminant central plus peripheral nervous system demyelination without antibodies to neurofascin","volume":"43","author":"Vural","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain-Barre and Miller Fisher syndromes\u2014new diagnostic classification","volume":"10","author":"Wakerley","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/847670","article-title":"Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica","volume":"2013","author":"Warabi","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"Suppl","key":"10.1016\/j.jneuroim.2018.02.006_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.410090710","article-title":"The protein antigens of peripheral nerve myelin","volume":"9","author":"Whitaker","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.02.006_bb0115","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneurol.2010.143","article-title":"Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"67","author":"Wolf","year":"2010","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2018.02.006_bb0120","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/jnnp.2006.108290","article-title":"Relapsing demyelinating disease affecting both the central and peripheral nervous systems","volume":"79","author":"Zephir","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817305167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817305167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:30:37Z","timestamp":1759048237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817305167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"alternative-id":["S0165572817305167"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical features of combined central and peripheral demyelination in Chinese patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}